Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neoplasms, Unknown Primary × HhAntag691 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Basal Cell 13 Neoplasms 4 Basal Cell Nevus Syndrome 3 Stomach Neoplasms 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Multiple Myeloma 2 Medulloblastoma 2 Colorectal Neoplasms 2 Adenocarcinoma 2 Urinary Bladder Neoplasms 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Recurrence 1 Pancreatic Diseases 1 Odontogenic Cysts 1 Neuroectodermal Tumors, Primitive 1 Neoplasms, Unknown Primary 1 Neoplasms, Basal Cell 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Meningioma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Leukemia, Myeloid 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Infratentorial Neoplasms 1

Interventions

Gemcitabine 8 Carboplatin 8 Paclitaxel 6 Capecitabine 4 Irinotecan 3 Bevacizumab 3 pembrolizumab 2 atezolizumab 2 Peripheral Blood Stem Cell Transplantation 2 Oxaliplatin 2 Filgrastim 2 Erlotinib Hydrochloride 2 Cisplatin 2 CP protocol 2 tegafur-gimeracil-oteracil 1 sintilimab 1 pertuzumab 1 pemigatinib 1 olaparib 1 ivosidenib 1 ipatasertib 1 etoposide phosphate 1 entrectinib 1 cobimetinib 1 belinostat 1 antineoplaston AS 2-1 1 antineoplaston A10 1 alectinib 1 Vemurafenib 1 Transurethral Resection of Prostate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03498521 2025-11-19

CUPISCO

Hoffmann-La Roche

Phase 2 Completed

529 enrolled 16 charts

Neoplasms, Unknown Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡